The FDA's new rule restricting the sale of compounded semaglutide could make it more difficult for some people to obtain ...

The Good Bug’s formulation, priced at Rs 2,000 per month, is based on microbiome research. A randomised, double-blinded, ...

Eli Lilly is broadening its direct-to-consumer approach by partnering with a digital health company, Noom, which is focused ...

The drug discovery company, which has partnerships with Eli Lilly and Novartis, is developing AI models to design drugs and ...

Building upon its already impressive obesity drug portfolio, Novo Nordisk A/S has licensed a triple agonist of the receptors for GLP-1, GIP and glucagon from United Biotechnology Co. Ltd. China-based ...

Novo Nordisk’s attempt to create a successor to its weight loss blockbuster Wegovy may have taken a hit with recent ...

Diabetes management and weight-loss drug Mounjaro has been launched in India by makers Eli Lilly, following approval ... and GLP-1 (glucagon-like peptide-1) hormone receptors in adults with ...

Global pharmaceutical company Eli Lilly and Company (India ... GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors, offering a new approach to ...

Approved by the Central Drugs Standard Control Organization (CDSCO), Mounjaro® is available in single-dose vials, with pricing set at Rs3,500 for a 2.5 mg vial and Rs4,375 for a 5 mg vial ...

(Image Credits: Pexels) Eli Lilly and Company (India ... both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors. “Mounjaro is indicated ...

Obesity is linked to more than 200 health complications, including hypertension The 2.5 mg vial is priced at 3,500 rupees ($40.5) and the 5 mg vial is priced at 4,375 rupees. Bloomberg Follow ...

NEW DELHI: US-based pharmaceutical giant Eli Lilly has launched its blockbuster ... dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors, making it a ...